Showing results (111-120 of 563) with videos related to

Sort By:
Pageof 57
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|April 23, 2013
[Correlations between OCT4 expression and clinicopathological factors and prognosis of patients with lung adenocarcinoma]Xueyan Zhang, Huimin Wang, Bo Jin, et al.
Oxidative Medicine and Cellular Longevity|May 16, 2022
A Promising Insight: The Potential Influence and Therapeutic Value of the Gut Microbiota in GI GVHDJiahua Li, Xueyan Zhang, Yiru Chen, et al.
Head & Neck|November 11, 2022
Neutrophil-to-lymphocyte and hypopharyngeal cancer prognosis: System review and meta-analysisXianyang Hu, Tengfei Tian, Xueyan Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)|December 30, 2025
Inavolisib for PIK3CA-mutant non-small cell lung cancer: A case reportLei Cheng, Dongying Wang, Xueyan Zhang, et al.
Macromolecular Rapid Communications|October 29, 2024
Emissive Hydrazone-Linked Covalent Organic Frameworks as Highly Sensitive and Selective Sensor for the Hydrazine DetectionLongjin Liu, Dongxue Wei, Hao Liang, et al.
Molecular Pharmaceutics|August 10, 2021
Treatment of Melanoma by Nano-conjugate-Delivered Wee1 siRNAXueyan Zhang, Anqi Cai, Yan Gao, et al.
International Journal of Medical Sciences|August 29, 2022
GnRH receptor mediates lipid storage in female adipocytes via AMPK pathwayXiaoyong Li, Xueyan Zhang, Zhaojun Shen, et al.
Chemical Communications (Cambridge, England)|August 14, 2018
Doping-free circularly polarized electroluminescence of AIE-active chiral binaphthyl-based polymersLan Yang, Yu Zhang, Xueyan Zhang, et al.
Biomed Research International|January 18, 2020
Safety and Efficacy in Relapsed or Refractory Classic Hodgkin's Lymphoma Treated with PD-1 Inhibitors: A Meta-Analysis of 9 Prospective Clinical TrialsXueyan Zhang, Li Chen, Yawei Zhao, et al.
Ophthalmology and Therapy|December 30, 2022
Retinal Vascular Geometry in Hypertension: cSLO-Based MethodHongyu Kong, Wei Lou, Jiaojie Li, et al.
Pageof 57